Izumi, Hiroto
University of Occupational and Environmental Health Japan
4 papers on CoChatORCID 0000-0003-0327-582X
Most cited papers
- Verified
Loss of PTEN expression by blocking nuclear translocation of EGR1 in gefitinib-resistant lung cancer cells harboring epidermal growth factor receptor-activating mutations
Yamamoto, C., Basaki, Y., Kawahara, A., Nakashima, K., Kage, M., Izumi, H., Kohno, K., Uramoto, H., Yasumoto, K., Kuwano, M., et al. (2010) · Cancer Research
Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research
Cited by 155
- Verified
Programmed Cell Death Protein 4 Down-regulates Y-Box Binding Protein-1 Expression via a Direct Interaction with Twist1 to Suppress Cancer Cell Growth
Shiota, M., Izumi, H., Tanimoto, A., Takahashi, M., Miyamoto, N., Kashiwagi, E., Kidani, A., Hirano, G., Masubuchi, D., Fukunaka, Y., et al. (2009) · Cancer Research
Cancer-related Molecular PathwaysCell death mechanisms and regulation
Cited by 134
- Verified
Pulmonary toxicity of well-dispersed cerium oxide nanoparticles following intratracheal instillation and inhalation
Morimoto, Y., Izumi, H., Yoshiura, Y., Tomonaga, T., Oyabu, T., Myojo, T., Kawai, K., Yatera, K., Shimada, M., Kubo, M., et al. (2015) · Journal of Nanoparticle Research
Nanoparticles: synthesis and applicationsImmunotoxicology and immune responses
Cited by 83
- Verified
Y-box binding protein 1 enhances DNA topoisomerase 1 activity and sensitivity to camptothecin via direct interaction
Wu, Y., Wang, K.-Y., Li, Z., Liu, Y.-P., Izumi, H., Uramoto, H., Nakayama, Y., Ito, K.-I., & Kohno, K. (2014) · Journal of Experimental & Clinical Cancer Research
Cancer therapeutics and mechanismsBioactive Compounds and Antitumor Agents
Cited by 17
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free